QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$39.69 USD
-1.13 (-2.77%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $39.67 -0.02 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
B Value D Growth F Momentum C VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenues by business unit: Labs
- 1,425.40
- 1,331.20
- 44.80
- 50.90
- --
- Revenue - Line of Business (LOBR)
- Revenues by business unit: Transfusion Medicine
- 648.50
- 668.10
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenues by business unit: Point of Care
- 892.20
- 1,955.20
- 1,453.30
- 1,387.80
- --
- Revenue - Line of Business (LOBR)
- Revenues by business unit: Molecular Diagnostics
- 31.70
- 96.70
- 200.50
- 222.96
- 21.72
- Revenue - Geographic (GEOR)
- Revenues: North America
- 1,877.10
- 2,536.50
- 1,500.20
- 1,460.70
- --
- Revenue - Geographic (GEOR)
- Revenues: EMEA
- 327.30
- 206.80
- 69.60
- 92.90
- --
- Revenue - Geographic (GEOR)
- Revenues: China
- 310.10
- 220.00
- 58.00
- 62.40
- --
- Revenue - Geographic (GEOR)
- Revenues: Other
- 483.30
- 302.70
- 70.80
- 45.70
- --
- Income - Geographic (GEOI)
- Adjusted EBITDA: North America
- 949.20
- 1,614.60
- 1,028.50
- 1,205.20
- --
- Income - Geographic (GEOI)
- Adjusted EBITDA: EMEA
- 58.30
- 31.70
- 28.10
- 55.50
- --
- Income - Geographic (GEOI)
- Adjusted EBITDA: China
- 129.10
- 104.10
- 24.10
- 30.50
- --
- Income - Geographic (GEOI)
- Adjusted EBITDA: Other
- 116.30
- 92.70
- 43.00
- 28.00
- --